Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli

Psychopharmacology

Volumn 195, Issue 4, 2008, Pages 537-546

  Franken, Ingmar H A ^a   Nijs, Ilse ^a   Pepplinkhuizen, Lolke ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Affective processing; Bromocriptine; Dopamine; ERP; Haloperidol

Indexed keywords

BROMOCRIPTINE; DOMPERIDONE; DOPAMINE; HALOPERIDOL; PLACEBO;

ADULT; AFFECT; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN REGION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPAMINERGIC ACTIVITY; DOUBLE BLIND PROCEDURE; EVENT RELATED POTENTIAL; HUMAN; MALE; NAUSEA; NEUROMODULATION; NEUROTRANSMISSION; NORMAL HUMAN; OCCIPITAL CORTEX; ORBITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REWARD; SELF REPORT; SINGLE DRUG DOSE; TEMPORAL CORTEX; VISUAL STIMULATION;

ADOLESCENT; ADULT; AFFECT; AROUSAL; ATTENTION; BRAIN MAPPING; BROMOCRIPTINE; CEREBRAL CORTEX; CROSS-OVER STUDIES; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, VISUAL; FACIAL EXPRESSION; HALOPERIDOL; HUMANS; MALE; MOTIVATION; PATTERN RECOGNITION, VISUAL; RECEPTORS, DOPAMINE D2; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 36348939389     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0941-6     Document Type: Article

References (45)

1. Ashby FG, Isen AM, Turken U (1999) A neuropsychological theory of positive affect and its influence on cognition. Psychol Rev 106:529-550
2. Barone JA (1999) Domperidone: a peripherally acting dopamine2-receptor antagonist. Ann Pharmacother 33:429-440
3. Boon MT, Peeters FP (1999) Affectieve dimensies bij depressie en angst [Dimensions of affectivity in depression and anxiety]. Tijdschrift voor Psychiatrie 41:109-113
4. Burgdorf J, Panksepp J (2006) The neurobiology of positive emotions. Neurosci Biobehav Rev 30:173-187
5. Cacioppo JT, Crites SL, Gardner WL, Bernston GG (1994) Bioelectrical echoes from evaluative categorizations: I. A late positive brain potential that varies as a function of trait negativity and extremity. J Pers Soc Psychol 67:115-125
6. Champion MC, Hartnett M, Yen M (1986) Domperidone, a new dopamine antagonist. Can Med Assoc J 135:457-461
7. Codispoti M, Ferrari V, Bradley MM (2007) Repetition and event-related potentials: Distinguishing early and late processes in affective picture perception. J Cogn Neurosci 19:577-586
8. Cuthbert BN, Schupp HT, Bradley MM, Birbaumer N, Lang PJ (2000) Brain potentials in affective picture processing: covariation with autonomic arousal and affective report. Biologic Psychol 52:95-111
9. Day JJ, Carelli RM (2007) The nucleus accumbens and Pavlovian reward learning. Neuroscientist 13:148-159
10. Dien J, Santuzzi AM (2005) Application of repeated measures ANOVA to high-density ERP data-sets: a review and tutorial. In: Handy TC (ed) Event-related potentials: a methods handbook. The MIT Press, Cambridge, pp 57-82
11. Ford JM, White PM, Csernansky JG, Faustman WO, Roth WT, Pfefferbaum A (1994) ERPs in schizophrenia: effects of antipsychotic medication. Biol Psychiatry 36:153-170
12. Franken IHA (2003) Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Prog Neuropsychopharmacol Biol Psychiatry 27:563-579
13. Franken IHA, Hendriks VM, Stam CJ, van den Brink W (2004) A role for dopamine in the processing of drug cues in heroin dependent patients. Eur Neuropsychopharmacol 14:503-508
14. Franken IHA, Nijs IMT, Muris P, Van Strien JW (2007) Alcohol selectively reduces brain activity during the affective processing of negative information. Alcoholism: Clinical and Experimental Research 31:919-927
15. Gratton G, Coles MGH, Donchin E (1983) A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 55:468-484
16. Jarvik ME, Caskey NH, Wirshing WC, Madsen DC, Iwamoto-Schaap PN, Elins JL, Eisenberger NI, Olmstead RE (2000) Bromocriptine reduces cigarette smoking. Addiction 95:1173-1183
17. Kahkonen S, Ahveninen J, Jaaskelainen IP, Kaakkola S, Naatanen R, Huttunen J, Pekkonen E (2001) Effects of haloperidol on selective attention: a combined whole-head MEG and high-resolution EEG study. Neuropsychopharmacology 25:498-504
18. Kapur S (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160:13-23
19. Keil A, Muller MM, Gruber T, Wienbruch C, Stolarova M, Elbert T (2001) Effects of emotional arousal in the cerebral hemispheres: a study of oscillatory brain activity and event-related potentials. Clin Neurophysiol 112:2057-2068
20. Keil A, Bradley MM, Hauk O, Rockstroh B, Elbert T, Lang PJ (2002) Large-scale neural correlates of affective picture processing. Psychophysiology 39:641-649
21. Kemp AH, Gray MA, Silberstein RB, Armstrong SM, Nathan PJ (2004) Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans. NeuroImage 22:1084-1096
22. Kirsch P, Reuter M, Mier D, Lonsdorf T, Stark R, Gallhofer B, Vaitl D, Hennig J (2006) Imaging gene-substance interactions: The effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neurosci Lett 405:196-201
23. Lang PJ, Bradley MM, Cuthbert BN (1999) International affective picture system (IAPS): instruction manual and affective ratings. The Center for Research in Psychophysiology, University of Florida, Gainsville, FL
24. Mitul AM, Rachel S, Alan DO, Barbara S, Trevor WR (2001) Improved short-term spatial memory but impaired reversal learning following the dopamine D2 agonist bromocriptine in human volunteers. Psychopharmacology 159:10-20
25. Mizrahi R, Rusjan P, Agid O, Graff A, Mamo DC, Zipursky RB, Kapur S (2007) Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. Am J Psychiatry 164:630-637
26. Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS (2004) Increasing dopaminergic activity: effects of l-dopa and bromocriptine on human sensory gating. J Psychopharmacol 18:388-394
27. Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS (2006) No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention. J Psychopharmacol 20:789-798
28. Robbins TW, Everitt BJ (2007) A role for mesencephalic dopamine in activation: commentary on Berridge (2006). Psychopharmacology 191:433-437
29. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291
30. Rule RR, Shimamura AP, Knight RT (2002) Orbitofrontal cortex and dynamic filtering of emotional stimuli. Cogn Affect Behav Neurosci 2:264-270
31. Saeedi H, Remington G, Christensen BK (2006) Impact of haloperidol, a dopamine D2 antagonist, on cognition and mood. Schizophr Res 85:222-231
32. Schultz W (1997) Dopamine neurons and their role in reward mechanisms. Curr Opin Neurobiol 7:191-197
33. Schupp HT, Cuthbert BN, Bradley MM, Cacioppo JT, Ito T, Lang PJ (2000) Affective picture processing: The late positive potential is modulated by motivational relevance. Psychophysiology 37:257-261
34. Schupp HT, Junghoefer M, Weike AI, Hamm AO (2003a) Attention and emotion: an ERP analysis of facilitated emotional stimulus processing. Neuroreport 14:1107-1110
35. Schupp HT, Junghoefer M, Weike AI, Hamm AO (2003b) Emotional facilitation of sensory processing in the visual cortex. Psychol Sci 14:7-13
36. Schupp HT, Flaisch T, Stockburger J, Junghofer M (2006) Emotion and attention: event-related brain potential studies. Prog Brain Res 156:31-51
37. Schupp HT, Stockburger J, Codispoti M, Junghofer M, Weike AI, Hamm AO (2007) Selective visual attention to emotion. J Neurosci 27:1082-1089
38. Takahashi H, Yahata N, Koeda M, Takano A, Asai K, Suhara T, Okubo Y (2005) Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study. NeuroImage 27:991-1001
39. Taylor SF, Luan Phan K, Britton JC, Liberzon I (2005) Neural response to emotional salience in schizophrenia. Neuropsychopharmacology 30:984-995
40. Tessitore A, Hariri AR, Fera F, Smith WG, Chase TN, Hyde TM, Weinberger DR, Mattay VS (2002) Dopamine modulates the response of the human amygdala: a study in Parkinson's disease. J Neurosci 22:9099-9103
41. Vuilleumier P (2005) How brains beware: neural mechanisms of emotional attention. Trends Cogn Sci 9:585-594
42. Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: The PANAS Scales. J Pers Soc Psychol 54:1063-1070
43. Wieser MJ, Muhlberger A, Alpers GW, Macht M, Ellgring H, Pauli P (2006) Emotion processing in Parkinson's disease: dissociation between early neuronal processing and explicit ratings. Clin Neurophysiol 117:94-102
44. Willner P, Hale AS, Argyropoulos S (2005) Dopaminergic mechanism of antidepressant action in depressed patients. J Affect Dis 86:37-45
45. Wise RA, Bozarth MA (1985) Brain mechanisms of drug reward and euphoria. Psychiatry Med 3:445-460